Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity
T cells represent a lymphocyte population that resides at the boundary between innate and adaptive immunity, presenting an attractive alternative for cellular therapy, including CAR T cell–based therapies.
